Endocrine Issues in the Pediatric Intensive Care Unit

Pediatric Clinics of North America

Volumn 55, Issue 3, 2008, Pages 805-833

  Clark, Lowell ^a,c   Preissig, Catherine ^b   Rigby, Mark R ^b   Bowyer, Frank ^a,c  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL CENTER OF CENTRAL GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; ESMOLOL; GLUCOCORTICOID; INSULIN; LEVOTHYROXINE; PROPRANOLOL DERIVATIVE; PROPYLTHIOURACIL; THIAMAZOLE; VASOPRESSIN;

ADRENAL INSUFFICIENCY; CARDIOVASCULAR SYMPTOM; CHILD CARE; DRUG MECHANISM; HYPERGLYCEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOPITUITARISM; INTENSIVE CARE UNIT; REVIEW; SALT LOSING NEPHRITIS; STRESS;

CHILD; CRITICAL ILLNESS; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; HOMEOSTASIS; HORMONES; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; PROGNOSIS;

EID: 44149111883     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.03.001     Document Type: Review

References (93)

1. Selye H. Nature (1936) 32
2. Selye H. Diseases of adaptation. Wis Med J 49 6 (1950) 515
3. Felmet K., and Carcillo J. Neuroendocrine-immune mediator coordination and disarray in critical illness. In: Fuhrman B.P., and Zimmerman J.J. (Eds). Pediatric critical care (2006), Mosby Elsevier, Philadelphia 1462-1473
4. Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23 (2002) 370-391
5. Low M.J. Neuroendocrinology. In: Kronenberg H.M., Melmed S., and Plolnsky K.S. (Eds). Williams textbook of endocrinology. 11th edition (2008), Saunders, Philadelphia 85-154
6. Jessop D.S., Harbuz M.S., and Lightman S.L. CRH in chronic inflammatory stress. Peptides 22 (2001) 803-807
7. Kacsoh B. The endocrine pancreas. Endocrine physiology (2000), McGraw-Hill, New York p. 360-99, 231-2
8. Vanhorebeek I., and Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 22 (2006) 1-15
9. Chicanza I.C. Prolactin and immunomodulation. Ann N Y Acad Sci 876 (1999) 119-130
10. Devins S.S., Miller A., Herndon B.L., et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 20 (1992) 1644-1649
11. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 290 15 (2003) 2041-2047
12. Stidham G., and Bugnitz M.C. The neuroendocrine response to stress. In: Rogers M.C. (Ed). Textbook of pediatric intensive care. 3rd edition (1996), Williams and Wilkins, Baltimore (MD) 1512
13. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 5 (2006) 449-461
14. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 11 (2006) 3151-3159
15. Jeremitsky E., Omert L.A., Dunham C.M., et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 58 1 (2005) 47-50
16. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
17. Yung M., Wilkins B., Norton L., et al. Glucose control, organ failure, and mortality in pediatric intensive care. Ped Crit Care Med 9 2 (2008) 147-152
18. Institute for Healthcare Improvement. Available at: www.ihi.org/ihi/topics/criticalcare/intensivecare/changes/implementeffec tiveglucose.html. Accessed October 14, 2007.
19. Garber A.J. American Diabetes Association position statement on inpatient diabetes and metabolic control. Endocr Pract 10 1 (2004) 77-82
20. Dellinger R.P. Surviving Sepsis Campaign guidelines for management of severe sepsis and shock. Campaign consortium statement. Crit Care Med 32 3 (2004) 858-873
21. Kido Y., Nakae J., and Domenico A. Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 86 (2001) 972-979
22. Vespa P., Boonyaputthikul R., McArthur D.L., et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 34 3 (2006) 850-856
23. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 146 1 (2005) 30-34
24. Branco R., Garcia R., Piva J., et al. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 6 No 4 (2005) 470-472
25. Van Waardenburg D.A., Jansen T.C., Vos G.D., et al. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 91 10 (2006) 3916-3921
26. Wintergerst K.A., Buckingham B., Gandrud L., et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 118 1 (2006) 173-179
27. Srinivasan V., Spinella P.C., Drott H.R., et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 5 4 (2004) 329-336
28. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 184 3 (1976) 333-339
29. Sprung C.L., Caralis P.V., Marcial E.H., et al. The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 311 (1984) 1137-1143
30. Bone R.C., Fisher Jr. C.J., Clemmer T.P., et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 (1987) 653-658
31. Veterans Administration Systemic Sepsis Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317 (1987) 659-665
32. Rothwell P.M., Udwadia Z.F., and Lawler P.G. Cortisol response to corticotrophin and survival in septic shock. Lancet 337 (1991) 582-583
33. Soni A., Pepper G.M., Wyrwinski P.M., et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 98 (1995) 266-271
34. Annane D., Sébille V., Troché G., et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 283 8 (2000) 1038-1045
35. Annane D., Sébille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 7 (2002) 862-871
36. Wagner R.L., White P.F., Kan P.B., et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 310 (1984) 1415-1421
37. Absolom A., Pledger D., and Kong A. Adrenocortical function in critically ill patients after a single dose of etomidate. Anaesthesia 54 (1999) 861-867
38. Ledingham I.M., and Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1 8336 (1983) 1270
39. Keh D., and Sprung C.L. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 32 11 (2004) S527-S533
40. Annane D., Bellisant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock. BMJ 329 (2004) 480-488
41. Pizarro C.F., Troster E.J., and Damaini D. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 33 4 (2005) 855-859
42. Zaloga G.P., and Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 17 1 (2001) 25-41
43. Menon K., and Clarson C. Adrenal function in pediatric critical illness. Pediatr Crit Care Med 3 2 (2002) 112-116
44. Beishuizen A., and Lambertus G.T. Relative adrenal failure in intensive care: an identifiable problem requiring treatment?. Best Pract Res Clin Endocrinol Metab 4 (2001) 513-531
45. Zimmerman J. Testing the waters. Pediatr Crit Care Med 8 3 (2007) 305-307
46. Hamrahian A.H., Oseni T.S., and Arafah B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 350 (2004) 1629-1638
47. Arafah B.M., Nishiyama F.J., Tlaygeh H., et al. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of circulating free cortisol. J Clin Endocrinol Metab 92 8 (2007) 2965-2971
48. Beishuizen A., Vermes I., and Hylkema B.S. Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 353 (1999) 1675-1676
49. Loriaux L. Glucocorticoid therapy in the intensive care unit. N Engl J Med 350 (2004) 1601-1602
50. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008) 111-124
51. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 1 (2008) 296-327
52. Carcillo J.A., Fields A.I., and Task Force Committee Members. ACCM clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 30 (2002) 1365-1378
53. Markovitz B.P., Goodman D.M., Watson S., et al. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids?. Pediatr Crit Care Med 6 (2005) 270-274
54. Finfer S. Corticosteroids in septic shock. N Engl J Med 358 (2008) 188-190
55. Singh S., Bohn D., and Carlotti A.P.C.P. Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 30 11 (2002) 2575-2579
56. Robinson A.G., and Verbalis J.G. In: Kronenberg H.M., Melmed S., and Plolnsky K.S. (Eds). Williams textbook of endocrinology. 11th edition (2008), Saunders, Philadelphia 263-268
57. Robertson G.L. Physiology of ADH secretion. Kidney Int Suppl 21 (1987) S20-S26
58. Thrasher T.N. Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors. Front Neuroendocrinol 15 (1994) 157-196
59. Dluhy R.G., Lawrence J.E., and Williams G.H. In: Larsen P.R., Kronenberg H.M., and Melmed S. (Eds). Williams textbook of endocrinology. 10th edition (2003), Saunders, Philadelphia 562-564
60. Levin E.R., Gardnere D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
61. Schwartz W.B., Bennett W., Curelop S., et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23 (1957) 529-542
62. Feldman B.J., Rosenthal S.M., Vargas G.A., et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352 (2005) 1884-1890
63. Robertson G.L. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119 (2006) S36-S42
64. Rose B.D., and Post T.W. Antidiuretic hormone and water balance. Available at:. http://www.utd.com Accessed August 19, 2007
65. Rose B.D. Diagnosis of hyponatremia. Available at:. http://www.utd.com Accessed July 19, 2007
66. Field M.J., Stanton B.A., and Giebisch G. Influence of ADH on renal potassium handling. Kidney Int 25 (1984) 502-511
67. Murase T. Mechanisms and therapy of osmotic demyelination. Am J Med 119 7 Suppl 1 (2006) S69-S73
68. Rose B.D. New approach to disturbances in the plasma sodium concentration. Am J Med 81 6 (1986) 1033-1040
69. Palm C., Pistrosch F., Herbrig K., et al. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med 119 7A (2006) S87-S92
70. Peters J.P., Welt L.G., Sims E.A.H., et al. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63 (1950) 57-64
71. Cort J.H. Cerebral salt wasting. Lancet 1 (1954) 752-754
72. Chung H.M., Kluge R., and Schrier R.W. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 83 (1987) 905-908
73. Palmer B.F. Hyponatremia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone versus cerebral salt wasting. Nephrol Dial Transplant 15 (2000) 262-268
74. Guyton A.C., and Hall J.E. Sympathetic nervous system activation increases sodium reabsorption. Textbook of medical physiology (2000), W.B. Saunders, Philadelphia 309
75. Guyton A.C., and Hall J.E. Effect of pressure on urine output-the pressure-natriuresis and pressure-diuresis mechanisms. Textbook of medical physiology (2000), W.B. Saunders, Philadelphia 308
76. Zhang Y., Mircheff A.K., Hijdra A., et al. Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis. Am J Physiol 270 (1996) F1004-F1014
77. Gowrishankar M., Lin S.H., Mallie J.P., et al. Acute hyponatremia in the perioperative period: insights into its pathophysiology and recommendations for management. Clin Nephrol 50 (1998) 352-360
78. Taplin C.E., Cowell C.T., Silink M., et al. Fludrocortisone therapy in cerebral salt wasting. Pediatrics 118 6 (2006) e1904-e1908
79. Kohane D.S., Tobin J.R., and Kohane I.S. Endocrine, mineral, and metabolic disease in pediatric intensive care. In: Rogers M.C. (Ed). Textbook of pediatric intensive care. 3rd edition (1996), Williams and Wilkins, Baltimore (MD) 1247-1260
80. Oberfield S.E., Gallagher M.P., and Levine L.S. Endocrine hypertension. In: Finberg L., and Kleinman R.E. (Eds). Saunders manual of pediatric practice (2002), WB Saunders, Philadelphia 912-915
81. Chernausek S.D. Pheochromocytoma and the multiple endocrine neoplasia syndrome. In: Sperling M.A. (Ed). Pediatric endocrinology (2002), WB Saunders, Philadelphia 439-454
82. Styne D.N. Guide to pediatric endocrine emergencies. Pediatric endocrinology (2004), Lippincott Williams and Wilkins, Philadelphia 305
83. Ross J.H. Pheochomocytoma. Special considerations in children. Urol Clin North Am 27 (2000) 393-402
84. Kwon K.T., and Tsai V.W. Metabolic emergencies. Emerg Med Clin North Am 25 4 (2007) 1041-1060
85. Ringel M.D. Management of hypothyroidism and hyperthyroidism in the intensive care unit. Crit Care Clin 17 (2001) 59-74
86. Connell J.M., and Fraser R. Adrenal corticosteroid synthesis and hypertension. J Hypertens 9 (1991) 97-107
87. Kacsoh B. The thyroid gland. Endocrine physiology (2000), McGraw-Hill, New York p. 332, 340, 355
88. Miller W.L. The adrenal cortex. In: Sperling M. (Ed). Pediatric endocrinology. 2nd edition (2002), WB Saunders, Philadelphia 427
89. Aron D.C., Findling J.M., and Tyrell J.B. Hypothalamus and pituitary gland. In: Gardner D.C., and Shobock J. (Eds). Greenspan's basic & clinical endocrinology. 8th edition (2007), McGraw-Hill, New York 138
90. Kacsoh B. The adrenal gland. Endocrine physiology (2000), McGraw-Hill, New York 447
91. Muglia L.J., and Majzoub J.A. Disorders of the posterior pituitary. In: Sperling M. (Ed). Pediatric endocrinology. 2nd edition (2002), WB Saunders, Philadelphia 308-310
92. Raine J.E., Donaldson M.D.C., Gregory J.W., et al. Thyroid disorders. Practical endocrinology and diabetes in children. 2nd edition (2006), Blackwell Publishing, Ltd., Massachusetts 101
93. Dallas J.S., and Foley T.P. Hyperthyroidism. In: Lifshitz F. (Ed). Pediatric endocrinology. 5th edition (2007), Informa Healthcare USA, Inc., New York p. 419, 430-7